(Q46601158)

23 December 2017

title

Herbal medicine Shakuyaku-kanzo-to reduces paclitaxel-induced painful peripheral neuropathy in mice (English)

1 reference

23 December 2017

main subject

peripheral neuropathy

1 reference

0 references

9

Shigeru Saito

1 reference

23 December 2017

author name string

Takao Hidaka

1

1 reference

23 December 2017

Tomoko Shima

2

1 reference

23 December 2017

Kiyofumi Nagira

3

1 reference

23 December 2017

Masahiro Ieki

4

1 reference

23 December 2017

Takafumi Nakamura

5

1 reference

23 December 2017

Yukiko Aono

6

1 reference

23 December 2017

Yasushi Kuraishi

7

1 reference

23 December 2017

Takashi Arai

8

1 reference

23 December 2017

publication date

9 May 2008

1 reference

23 December 2017

published in

European Journal of Pain

1 reference

23 December 2017

volume

13

1 reference

23 December 2017

issue

1

1 reference

23 December 2017

page(s)

22-27

1 reference

23 December 2017

Description of a short-term Taxol-induced nociceptive neuropathy in rats

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.03.003

Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.03.003

Peripheral neurotoxicity of taxol in patients previously treated with cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.03.003

Role of protein kinase Cepsilon and protein kinase A in a model of paclitaxel-induced painful peripheral neuropathy in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.03.003

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.03.003

Phase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.03.003

Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.03.003

Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.03.003

Randomized study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group comparing quality of life in patients with ovarian cancer treated with cisplatin/paclitaxel versus carboplatin/paclitaxel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.03.003

Peripheral neuropathy induced by microtubule-stabilizing agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.03.003

Effect of shakuyaku-kanzoh-toh, a prescription composed of shakuyaku (Paeoniae Radix) and kanzoh (Glycyrrhizae Radix) on guinea pig ileum

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.03.003

Inhibition of paclitaxel-induced A-fiber hypersensitization by gabapentin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.03.003

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.03.003

Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.03.003

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.03.003

A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.03.003

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.03.003

A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.03.003

Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.03.003

Paclitaxel-induced neuropathic hypersensitivity in mice: responses in 10 inbred mouse strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.03.003

Allodynia and hyperalgesia induced by herpes simplex virus type-1 infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.03.003

Effects of shakuyaku-kanzo-to on muscle pain from combination chemotherapy with paclitaxel and carboplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.03.003

Ethical guidelines for investigations of experimental pain in conscious animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.03.003

10.1016/J.EJPAIN.2008.03.003

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017